Barbara Duncan

Overview

Barbara Duncan received an average of $1M in total compensation, including $351K in salary, at Intercept Pharmaceuticals from 2011 to 2015.

Source: SEC filings on June 20, 2016 and April 12, 2013.

Related executives

We found 16 more executives who work or worked at Intercept Pharmaceuticals.

Jerome Durso

Intercept Pharmaceuticals

Chief Executive Officer

Jared Freedberg

Intercept Pharmaceuticals

General Counsel

Michelle Berrey

Intercept Pharmaceuticals

Chief Medical Officer

Gail Cawkwell

Intercept Pharmaceuticals

SVP Medical Affairs, Safety & Pharmacovigilance

Andrew Saik

Intercept Pharmaceuticals

Chief Financial Officer

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

Rocco Venezia

Intercept Pharmaceuticals

Chief Financial Officer

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

You may also like